Cough-assist systems with humidifier bypass

Information

  • Patent Grant
  • 11679229
  • Patent Number
    11,679,229
  • Date Filed
    Thursday, August 13, 2020
    3 years ago
  • Date Issued
    Tuesday, June 20, 2023
    11 months ago
Abstract
The present technology relates generally to cough-assist devices with humidified cough assistance. In one example, a system includes a cough-assist device having a first phase configured to provide insufflating gas to a patient circuit and a second phase configured to draw exsufflating gas from the patient circuit. A humidifier is disposed between the cough-assist device and a distal end of the patient circuit, the humidifier including a chamber configured to contain heated water and fluidically coupled to the cough-assist device and the patient circuit. The system further includes a bypass configured to (a) direct insufflating gas from the cough-assist device through a first route to the patient circuit such that the insufflating gas is humidified in the chamber, and (b) route exsufflating gas from the patient circuit through a second route to the cough-assist device such that the exsufflating gas bypasses the chamber.
Description
TECHNICAL FIELD

The present technology is generally related to humidifiers for ventilation and cough-assist systems.


BACKGROUND

Mechanical ventilators are used to assist with breathing. Conventional ventilators typically drive inspiratory gases including oxygen into the patient's lungs. Many patients who use a ventilator also need other types of assistance related to treating and maintaining their airways and lungs, such as cough assistance. Currently, to receive cough assistance, a patient must be disconnected from the mechanical ventilator and connected to a separate cough-assist device. After cough assistance is performed, the patient must be disconnected from the cough-assist device and reconnected to the mechanical ventilator. Often, the patient airway is also suctioned after the patient has been disconnected from the cough-assist device and reconnected to the mechanical ventilator to remove remaining secretions in the patient airway after the cough assistance. Because this process may be tedious, it is often not performed in a manner that is most advantageous to the patient.


Thus, a need exists for ventilators to provide additional functionality beyond delivering inspiratory gases into the patient's lungs, such as cough assistance and humidification. The present technology provides these and other advantages as will be apparent from the following detailed description and accompanying figures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram illustrating a system that includes a ventilator for use by a human patient.



FIG. 2A is a schematic diagram illustrating components of a ventilator assembly of the ventilator of FIG. 1 with a cough-assist valve of the ventilator assembly depicted in a first configuration.



FIG. 2B is a schematic diagram illustrating the cough-assist valve of the ventilator assembly in a second configuration.



FIG. 3 illustrates a ventilation system including a ventilator with integrated cough-assist functionality, a patient circuit, a humidifier, and a humidifier bypass system.



FIGS. 4A-4D illustrate various views of a humidifier bypass system.



FIGS. 5A and 5B illustrate cross-sectional views of another embodiment of a humidifier bypass system.





DETAILED DESCRIPTION

Patients on ventilators often need humidification of both the inspiratory gas provided to the patient and insufflation gas for assisted cough therapy (also referred to as mechanical insufflation-exsufflation). Equipping a ventilator with cough-assistance capabilities eliminates the need to change the patient circuit to transition between ventilation and cough therapy. However, the present inventors have noted that the high exsufflation flows during cough assistance that pass through the humidifier chamber cause water to travel back to the ventilator. To alleviate this problem, the present technology is directed to a humidifier bypass that permits insufflating gas to pass through a humidifier chamber to the patient and routes exsufflating gas back to the ventilator without passing through the humidifier chamber.


The purpose of the ventilator bypass is to redirect the exsufflation flow around the humidifier chamber to prevent the exsufflation flow from blowing water in the chamber back to the ventilator. The bypass can be a passive accessory that connects to standard commercially available humidifier chambers. The bypass can remain in line between the ventilator and the patient following cough therapy. When ventilation resumes, the inspired gas is delivered through the humidifier chamber as if the bypass were not present.


In addition, the bypass may also be used by ventilator patients with standalone cough-assist machines. Typically, the patient circuit is disconnected at the patient to perform cough therapy. Dedicated patient tubing on the cough machine is then connected to the patient. With invasive ventilation, patients can experience discomfort when manipulating tubing so close to the tracheostomy site and there is some risk of accidental decannulation. And, in this scenario, humidified gas is no longer delivered to the patient until ventilation resumes and the humidifier is back in line. Humidifier bypass systems in accordance with embodiments of the present technology enable the patient circuit to be disconnected anywhere between the ventilator and humidifier rather than disconnecting at the patient. Humidified gas is accordingly delivered during insufflation, but the bypass prevents ingress of water from the humidifier into the cough-assist machine during exsufflation.


Further specific details of several embodiments of the present technology are described below with reference to FIGS. 1-5B. Although many of the embodiments are described below with respect to devices, systems, and methods for ventilation with humidified cough assistance, other embodiments are within the scope of the present technology. Additionally, other embodiments of the present technology can have different configurations, components, and/or procedures than those described herein. For example, other embodiments can include additional elements and features beyond those described herein, or other embodiments may not include several of the elements and features shown and described herein.


For ease of reference, throughout this disclosure identical reference numbers are used to identify similar or analogous components or features, but components identified by the same reference number are not necessarily identical. Indeed, in many examples described herein, the identically numbered parts are distinct in structure and/or function.



FIG. 1 is a block diagram illustrating a system 10 that includes a ventilator 100 with integrated humidified cough assistance in accordance with the embodiment of the present technology. Several general aspects of the system 10 will be described initially to provide an understanding of the components related to embodiments of the humidified bypass devices of the present technology. The ventilator 100 may be configured to provide both traditional volume-controlled ventilation and pressure-controlled ventilation. The ventilator 100 has an optional multi-lumen tube connection 103, a main ventilator connection 104, and a patient oxygen outlet 105. The system 100 also has a patient connection 106 (e.g., a tracheal tube, a nasal mask, a mouthpiece, and the like) and a patient circuit 110 that fluidically couples the patient connection 106 to the main ventilator connection 104 and/or the patient oxygen outlet 105.


The patient circuit 110 may be an active patient circuit or a passive patient circuit. Optionally, when the patient circuit 110 is an active patient circuit, the patient circuit 110 may include one or more ports 111 configured to be connected to the optional multi-lumen tube connection 103. The port(s) 111 allow one or more pressure signals 109 to flow between the optional multi-lumen tube connection 103 and the patient circuit 110. The pressure signals 109 may be gas(es) obtained from a fluid (and/or gas) source for which a pressure is to be measured. The gas(es) obtained are at the same pressure as the fluid (and/or gas) source.


The system 100 further includes humidifier 141 in line with the patient circuit 110 and the main ventilator connection 104. In some embodiments, the patient circuit 110 includes a tube or conduit that extends between the humidifier 141 and the main ventilator connection 104 in addition to a tube or conduit that extends between the humidifier 141 and the patient connection 106. The system 100, or more specifically the humidifier 141, can be equipped with a bypass 142 as described in more detail below.


The main ventilator connection 104 is configured to provide gases 112 that include air 114 optionally mixed with oxygen. While identified as being “air,” those of ordinary skill in the art appreciate that the air 114 may include ambient air or pressurized air obtained from any source external to the ventilator 100. The gases 112 may be inspiratory gases for the inspiratory phase of a breath or insufflation gases for the insufflation phase of cough assistance. The main ventilator connection 104 is configured to receive gases 113, which may include exsufflation gases exhaled by the patient 102 during an exsufflation phase of cough assistance.


The air 114 is received by the ventilator 100 via a patient air intake 116. Oxygen that is optionally mixed with the air 114 may be generated internally by the ventilator 100 and/or received from an optional low pressure oxygen source 118 (e.g., an oxygen concentrator), and/or an optional high pressure oxygen source 120. When the oxygen is generated internally, the ventilator 100 may output exhaust gases (e.g., nitrogen-rich gas 122) via an outlet vent 124. Optionally, the ventilator 100 may include a low pressure oxygen inlet 126 configured to be coupled to the optional low pressure oxygen source 118 and receive optional low pressure oxygen 128 therefrom. The ventilator 100 may include an optional high pressure oxygen inlet 130 configured to be coupled to the optional high pressure oxygen source 120 and receive optional high pressure oxygen 132 therefrom.


The patient oxygen outlet 105 is configured to provide doses or pulses of oxygen 140 to the patient connection 106 via the patient circuit 110 that are synchronized with the patient's breathing. Unlike the gases 112 provided by the main ventilator connection 104, the pulses of oxygen 140 do not include the air 114.


The gases 112 and/or the pulses of oxygen 140 delivered to the humidifier 141 and the patient circuit 110 are conducted thereby as inspiratory or insufflation gases 108 to the patient connection 106, which at least in part conducts those gases into the patient's lung(s) 143. Whenever the patient exhales during the exhalation phase of a breath or exsufflates during an exsufflation phase of cough assistance, exhaled gases 107 enter the patient circuit 110 via the patient connection 106. Thus, the patient circuit 110 may contain one or more of the following gases: the gases 112 provided by the ventilator 100, the pulses of oxygen 140, and the exhaled gases 107. For ease of illustration, the gases inside the patient circuit 110 will be referred to hereafter as “patient gases.”


The ventilator 100 can optionally include a suction connection 150 configured to be coupled to an optional suction assembly 152. The ventilator 100 may provide suction 154 to the optional suction assembly 152 via the optional suction connection 150. The suction assembly 152 may be configured to be connected to the patient connection 106, a suction catheter (not shown) positionable inside the patient connection 106, and/or a drain (not shown).


The ventilator 100 can additionally include an optional nebulizer connection 160 configured to be coupled to an optional nebulizer assembly 162. The ventilator 100 may provide gases 164 (e.g., the air 114) to the optional nebulizer assembly 162 via the optional nebulizer connection 160. The optional nebulizer assembly 162 may be configured to be connected to the patient circuit 110. However, this is not a requirement. Optionally, the ventilator 100 may include an outlet port 166 through which exhaust 167 may exit from the ventilator 100.


The ventilator 100 may be configured to be portable and powered by an internal battery (not shown) and/or an external power source (not shown) such as a conventional wall outlet. The ventilator 100 further includes a ventilation assembly 190, a user interface 170, an oxygen assembly 172, a control system 174, and conventional monitoring and alarm systems 176. The control system 174 receives input information 196 (e.g., settings, parameter values, and the like) from the user interface 170, and provides output information 198 (e.g., performance information, status information, and the like) to the user interface 170. The user interface 170 is configured to receive input from a user (e.g., a caregiver, a clinician, and the like associated with a patient 102) and provide that input to the control system 174 in the input information 196. The user interface 170 is also configured to display the output information 198 to the user.


The ventilation assembly 190 may receive one or more control signals 192 from the control system 174, and the ventilation assembly 190 may provide one or more data signals 194 to the control system 174. The ventilation assembly 190 may also receive the pressure signals 109 from the patient circuit 110 via the multi-lumen connection 103. The oxygen assembly 172 may receive one or more control signals 178 from the control system 174, and the oxygen assembly 172 may provide one or more data signals 180 to the control system 174. The control signals 192 and 178 and the data signals 194 and 180 may be used by the control system 174 to monitor and/or control internal operations of the ventilator 100.



FIGS. 2A and 2B are schematic diagrams illustrating an embodiment of the ventilation assembly 190, the humidifier 141, and a bypass system 242. Referring to FIGS. 2A and 2B, the ventilation assembly 190 includes a cough-assist valve 204, an accumulator 202 and an internal bacteria filter 230. The cough-assist valve 204 is connected to (a) the accumulator 202 by a conduit or flow line 214, (b) the outlet port 166 by a conduit or flow line 215, and (c) the main ventilator connection 104 by a conduit or flow line 273. FIG. 2A depicts the cough-assist valve 204 in a first configuration for normal breathing and the insufflation phase of cough assistance, and FIG. 2B depicts the cough-assist valve 204 in a second configuration for the exsufflation phase of cough assistance.


Referring to FIG. 2A, in the first configuration, the cough-assist valve 204 receives a gas 252 from the accumulator 202 (via the flow line 214), and outputs the gas 252 to the main ventilator connection 104 (via the flow line 273). The gas 252 flowing through both the blower 222 and the cough-assist valve 204 during the inspiratory phase of a breath or the insufflation phase of a cough-assist maneuver performed by the ventilator 100 (see FIG. 1). During normal breathing/ventilation and the insufflation phase of cough assistance, the cough-assist valve 204 remains in the first configuration. Typical pressure ranges used to support normal breathing and ventilation can be from about 10-40 cm H2O during inspiration and from about 0-10 cm H2O during expiration. During cough assistance, the cough-assist valve 204 is in the first configuration (FIG. 2A) during the insufflation phase and the second configuration (FIG. 2B) during the exsufflation phase. Typical pressure ranges used provide cough-assist functionality are generally higher than for normal breathing/ventilation, such as from about 30-70 cm H2O during insufflation and from about negative 30-70 cm H2O during exsufflation.


The cough-assist valve 204 has a valve-to-blower outlet 206, a blower-to-valve inlet 208, an air intake 210, an exhaust outlet 212, and an aperture 213. The aperture 213 is connected to the main ventilator connection 104 by the flow line 273. As shown in FIG. 2A, when the cough-assist valve 204 is in the first configuration, the air intake 210 is in fluid communication with the valve-to-blower outlet 206, and the blower-to-valve inlet 208 is in fluid communication with the aperture 213. Further, the exhaust outlet 212 is closed such that both the valve-to-blower outlet 206 and the air intake 210 are in fluid communication with the aperture 213 via only the blower 222. Thus, the gas 252 may flow into the air intake 210, through a portion of the cough-assist valve 204 to the valve-to-blower outlet 206, and into the blower 222. The gas 252 exiting the blower 222 flows into the blower-to-valve inlet 208, through another portion of the cough-assist valve 204, and into the aperture 213. The aperture 213 is connected to the flow line 273, which conducts the gas 252 to the main ventilator connection 104.


During inspiration or insufflation, the gas 252 passes through the main ventilator connection 104, across the bacterial filter 230 and to the bypass system 242. In the embodiment shown in FIG. 2A, the bypass system 242 has a first valve 244 coupled to the humidifier 141 and a second valve 246. During normal breathing/ventilation and insufflation, the gas 252 flows through a first valve 244 and into the humidifier 141 where it is humidified. The gas 252 then is passed through the output of the bypass system 242 and to the patient circuit 110. The second valve 246 of the bypass system 242 prevents the gas 252 from passing directly to the patient circuit 110 without first going through the humidifier 141. The operation of the bypass system 242 is described in more detail below with respect to FIGS. 3-5B.


Referring to FIG. 2B, in the second configuration, the cough-assist valve 204 receives exsufflation gases 253 via the flow line 273 and outputs the exsufflation gases 253 (as the exhaust 167) to the outlet port 166 via the flow line 215. The exsufflation gases 253 flow through both the blower 222 and the cough-assist valve 204 during an exsufflation phase of cough assistance performed by the ventilator 100 (see FIG. 1).


As shown in FIG. 2B, when the cough-assist valve 204 is in the second configuration, the air intake 210 is closed, and the blower-to-valve inlet 208 and the exhaust outlet 212 are in fluid communication with the aperture 213 only via the blower 222. Further, the aperture 213 is in fluid communication with the valve-to-blower outlet 206, and the blower-to-valve inlet 208 is in fluid communication with the exhaust outlet 212. Thus, the exsufflation gases 253 flow into the aperture 213, across a portion of the cough-assist valve 204, to the valve-to-blower outlet 206, and into the blower 222. The exsufflation gas 253 exiting the blower 222 flows into the blower-to-valve inlet 208, through a portion of the cough-assist valve 204, and exits the cough-assist valve 204 though the exhaust outlet 212. The exhaust outlet 212 is connected to the flow line 215, which conducts the exsufflation gas 253 to the outlet port 166.


During exsufflation, the gas 253 passes through the patient circuit 110, through the second valve 246 of the bypass system 242, and across the bacterial filter 230 before reaching the main ventilator connection 104. The second valve 246 of the bypass system 242 permits the gas 253 to pass to the main ventilator connection 104, while the first valve 244 of the bypass system 242 prevents the gas 253 from passing back through the humidifier 141. For example, the first valve 244 closes during exsufflation flow to prohibit the gas 253 from passing back through the humidifier 141 to the main ventilator connection 144. As a result, the high velocity exsufflation gas 253 cannot entrain liquid from the humidifier 141 into the flow of gas 253 back into the ventilator 100. The operation of the bypass system 242 is described in more detail below with respect to FIGS. 3-5B.



FIG. 3 illustrates a system 300 including the ventilator 100 with integrated cough-assist functionality that is coupled to a patient circuit 110 and a humidifier 141 equipped with an embodiment of the bypass system 242. As illustrated, this embodiment of the humidifier 141 and the bypass system 242 are in line with the patient circuit 110. The patient circuit 110 includes a first tube 301 connected to the bacterial filter 230 and one side of the bypass system 242, and a second tube 303 connected to another side of the bypass system 242. A distal end 305 of the second tube 303 can be connected to the patient connection 106 (FIG. 1).


The humidifier 141 includes a base 307 having an integrated heater and a chamber 309 configured to retain water. In operation, the base 307 heats the water in the chamber 309 to produce water vapor. As a result, inspiration and insufflation gases passing through the chamber 309 are humidified before being delivered to the patient.


The bypass system 242 is in fluid communication with the chamber 309 as well as the first tube 301 and the second tube 303 of the patient circuit 110. In particular, the bypass system 242 includes a first conduit 311 that extends between the chamber 309 of the humidifier 141 and the first tube 301 of the patient circuit 110. The bypass system 242 additionally includes a second conduit 313 that extends between the chamber 309 of the humidifier 141 and the second tube 303 of the patient circuit 110. The bypass system 242 can also include a bridge 315 that is fluidically coupled to and extends between the first conduit 311 and the second conduit 313 at a position spaced apart from the chamber 309.


The first valve 244 is disposed in the first conduit 311 in a position below the intersection of the bridge 315 and the first conduit 311. The first valve 244 can be a one-way valve configured to open when the pressure is higher in the first tube 301 than the chamber 309, but close when the pressure in the chamber 309 is higher than in the first tube 301. As such, during inspiration or insufflation, gas flows from the ventilator 100, from the first tube 301 of the patient circuit 110 through the first conduit 311 and through the first valve 244 into the chamber 309 of the humidifier 141. However, during exhalation or exsufflation, gas is prevented from flowing back through the chamber 309 and up the first conduit 311.


The second valve 246 is disposed in the bridge 315 of the bypass system 242. The second valve 246 can be a one-way valve configured to open towards the first conduit 311 such that, during exsufflation, gas from the patient flows from the second tube 303 of the patient circuit 110 through the second conduit 313, through the bridge 315, and through the second valve 246 towards the ventilator 100. Thus, the opposite one-way directions and the positions of the first and second valves 244 and 246 direct the high-velocity exsufflation gas flow to the ventilator 100 without passing through the humidifier 141.


The first and second valves 244, 246 can be many different types of valves. For example, one or both of the valves 244, 246 can be ball check valves, diaphragm check valves, leaf valves, swing check valves, tilting disc check valves, clapper valves, or any other suitable valve that allows flow in one direction while disallowing flow in the opposite direction. The first and second valves 244, 246 can be passive valves configured to open in the presence of flow in one direction without the need for actuation. In other embodiments, one or both of the valves can be active valves that are electronically controlled to open or close in response to signals communicated from a controller (see FIG. 5).


The system 300 provides a first flowpath 317 through the bypass system 242. The first flowpath 317 receives gas flowing from the ventilator 100 through the first tube 301 of the patient circuit 110 and into the first conduit of the bypass system 242. The first valve 244 opens in the presence of gas flowing in the direction of the first flowpath 317 while the second valve 246 is closed. The first flowpath 317 therefore continues through the first valve 244, through the chamber 309 of the humidifier 141, and into the second conduit 313 of the bypass system 242. The first flowpath 317 delivers gas into the second tube 303 of the patient circuit 110 where it then passes through the distal end 305 of the patient circuit 110 and to the patient. In this first flowpath 317, the gases (e.g., gases provided by the ventilator 100 either in breathing assistance (inspiration) or cough-assistance (insufflation) mode) are humidified before reaching the distal end 305 of the patient circuit 110 and being delivered to the patient.


The system 300 also provides a second flowpath 319 through the bypass system 242. The second flowpath 319 receives gas flowing from the distal end 305 of the patient circuit 110 through the second tube 303 of the patient circuit and into the second conduit 313 of the bypass system 242. The first valve 244 remains closed in the presence of gas flowing in the direction of the second flowpath 319 while the second valve 246 is open. As a result, the second flowpath 319 continues through the bridge 315 and out through the first conduit 311 of the bypass system 242. The second flowpath 319 delivers gas into the first tube 301 of the patient circuit 110 where it then passes through the bacterial filter 230 and into the ventilator 100. In this second flowpath 319, the gases (e.g., exsufflation gases drawn from the patient during cough assistance) do not pass through the chamber 309 of the humidifier 141. As a result, the risk of liquid from the chamber 309 being passed through the first tube 301 of the patient circuit 110 into the bacterial filter 230 and/or the ventilator 100 is reduced.



FIGS. 4A-4D illustrate various views of an embodiment of the bypass system 242 coupled to the chamber 309 of a humidifier. FIG. 4A is a perspective view, FIG. 4B is a partially exploded view, FIG. 4C is a side view, and FIG. 4D is a cross-section taken along line 4D-4D in FIG. 4C. Referring to FIGS. 4A-4D together, the bypass system 242 is engaged with the chamber 309, and the chamber 309 can be configured to be coupled to a standard commercially available humidifier base. Once coupled to the humidifier base, liquid within the chamber 309 can be heated. The chamber 309 in the embodiment shown in FIGS. 4A-4D includes a body 401 with a first stem 403 and a second stem 405 projecting away from the body 401. The first conduit 311 of the bypass system 242 engages the first stem 403 of the chamber 309, and the first valve 244 is within the first conduit 311 such that gas passing through the first conduit 311 and into the body 401 of the chamber 309 through the first stem 403 must pass through the first valve 244. As described above with respect to FIG. 3, the first conduit 311 of the bypass system 242 connects to the first tube 301 of the patient circuit 110, which delivers gases to and from the ventilator 100.


The second conduit 313 of the bypass system 242 couples to the second stem 405 of the chamber 309. As noted previously, the second conduit 313 of the bypass system 242 connects to the second tube 303 of the patient circuit 110, which connects to the patient connector and delivers gases to and from the patient. The bridge 315 extends between the first conduit 311 and the second conduit 313 of the bypass system 242 and the second valve 246 is in the bridge 315.


The bypass system 242 can also have a re-filling port 407 coupled to the second stem 405 of the chamber 309. The re-filling port 407 can share a portion of tubing with the second conduit 313 such that liquid can be provided to the chamber 309 through the re-filling port 407. In other embodiments, the chamber 309 can be filled through a separate port.



FIGS. 5A and 5B illustrate cross-sectional views of another embodiment of a humidifier bypass system 501 in accordance with the present technology. The bypass system 501 can be generally similar to the bypass system 242 system illustrated in FIGS. 4A-4D, except that the bypass system 501 includes a single controllable valve 503 coupled to a controller 505 integrated in the control system 174 described above with respect to FIG. 1. The valve 503 can be moved between a first position (FIG. 5A) and a second position (FIG. 5B) in response to signals received from the controller 505. In the first position (FIG. 5A), the valve 503 allows inspiration or insufflation gases to pass through the first conduit 311, through the first stem 403, and into the chamber 309 where the gases are humidified before exiting via the second stem 405 and the second conduit 313 to the patient. In the second position (FIG. 5B), the valve 503 allows exsufflating gases to pass through the second conduit 313 across the bridge 315 and out through the first conduit 311 without passing through the chamber 309. When the valve 503 is in the second position, liquid in the chamber 309 is blocked from flowing back to the ventilator. The single controllable valve 503 therefore provides similar functionality to the two-valve system described above with respect to FIGS. 3-4D.


The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise forms disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments.


From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.


Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.

Claims
  • 1. A system comprising: a cough-assist device having a first phase configured to provide insufflating gas to a patient circuit and a second phase configured to draw exsufflating gas from the patient circuit;a humidifier positionable between the cough-assist device and a distal end of the patient circuit, the humidifier comprising a chamber fluidically coupleable to the cough-assist device and/or the patient circuit and configured to contain water and/or water vapor; anda bypass having a first conduit coupled to the chamber, a second conduit coupled to the chamber, and a bridge extending between the first conduit and the second conduit, wherein, when the humidifier is fluidically coupled to the cough-assist device and/or the patient circuit, the bypass is configured to— route insufflating gas from the cough-assist device to the patient through the first conduit, the chamber, and the second conduit such that the insufflating gas is humidified in the chamber, androute exsufflating gas from the patient circuit toward the cough-assist device through at least a portion of the first conduit, the bridge, and at least a portion of the second conduit such that at least a portion of the exsufflating gas bypasses the chamber.
  • 2. The system of claim 1 wherein the cough-assist device comprises a ventilator configured to provide breathing assistance in a first mode and cough assistance in a second mode.
  • 3. The system of claim 1 wherein the bypass comprises: the first conduit is configured to fluidically couple the cough-assist device to the chamber;the second conduit is configured to fluidically couple the chamber to the distal end of the patient circuit.
  • 4. The system of claim 3 wherein the bypass further comprises: a first valve disposed in the first conduit at a position between the chamber and the bridge; anda second valve disposed in the bridge at a position between the first conduit and the second conduit.
  • 5. The system of claim 4 wherein the first valve is a one-way valve configured to open towards the chamber in the presence of insufflating gas, and wherein the second valve is a one-way valve configured to open towards the first conduit in the presence of exsufflating gas.
  • 6. The system of claim 1 wherein the bypass comprises: a first valve configured to (a) open in the presence of insufflating gas so that insufflating gas from the cough-assist device passes through the chamber and (b) close in the presence of exsufflating gas to prevent exsufflating gas from exiting the chamber; anda second valve configured to (c) open in the presence of exsufflating gas from the patient circuit so that at least the portion of the exsufflating gas passes to the cough-assist device without passing through the chamber and (d) to close in the presence of insufflating gas.
  • 7. The system of claim 1 wherein the patient circuit includes a first lumen extending between the bypass and the cough-assist device and a second lumen extending between the bypass and the distal end of the patient circuit, and wherein both insufflating gas and exsufflating gas are routed through at least a portion of the first lumen and the second lumen.
  • 8. A system comprising: a cough-assist device having an insufflating module configured to provide an insufflating gas flow to a patient circuit and an exsufflating module configured to draw an exsufflating gas flow from the patient circuit;a humidifier configured to be fluidically coupled to the cough-assist device and the patient circuit, the humidifier having a chamber configured to contain water and/or water vapor; anda bypass having a first flow path between the cough-assist device and the chamber, a second flow path between the chamber and the patient circuit, and a third flow path between the first and second flow paths, wherein, when the humidifier is fluidically coupled to the cough-assist device and the patient circuit, the bypass is configured to— route insufflating gas through the chamber via the first and second flow paths, androute at least a portion of the exsufflating gas through the third flow path such that it bypasses the chamber.
  • 9. The system of claim 8 wherein the bypass includes a valve system, and wherein the valve system is configured to— block the third flow path during insufflation so that the insufflation gas flow passes through the chamber via the first and second flow paths, andopen the third flow path and block the first flow path during exsufflation such that at least the portion of the exsufflation gas flow passes through the third flow path and bypasses the chamber.
  • 10. The system of claim 9 wherein the valve system comprises: a first passive valve in the first flow path between the chamber and an intersection between the first flow path and the third flow path; anda second passive valve in the third flow path.
  • 11. The system of claim 10 wherein the first passive valve comprises a first check valve configured to open towards the chamber during insufflation, and wherein the second passive valve comprises a second check valve configured to open towards the first flow path during exsufflation.
  • 12. The system of claim 8 wherein the humidifier is configured to be fluidically coupled to a portion of the patient circuit that receives both insufflating gas and exsufflating gas.
  • 13. The system of claim 8 wherein the bypass is coupled to a portion of the patient circuit that receives both insufflating gas and exsufflating gas.
  • 14. The system of claim 8 wherein the patient circuit includes a first lumen extending between the bypass and the cough-assist device and a second lumen extending between the bypass and the distal end of the patient circuit, and wherein both insufflating gas and exsufflating gas are routed through at least a portion of the first lumen and the second lumen.
  • 15. A humidifier assembly, comprising: a chamber configured to retain liquid therein;a heater configured to deliver heat to liquid within the chamber; a first conduit extending from the chamber and configured to fluidically couple a cough-assist device to the chamber; a second conduit extending from the chamber and configured to fluidically couple the chamber to a patient circuit; and wherein the humidifier assembly is configured to: (i) route insufflating gas received from the cough-assist device through the first conduit, the chamber, and the second conduit to the patient circuit when the humidifier assembly is fluidically coupled to the patient circuit; and(ii) route at least a portion of the exsufflating gas received from the patient circuit from the second conduit to the first conduit without passing through the chamber when the humidifier assembly is fluidically coupled to the patient circuit.
  • 16. The humidifier assembly of claim 15, further comprising a bridge connecting the first conduit and the second conduit.
  • 17. The humidifier assembly of claim 16, further comprising a first valve disposed in the first conduit at a position between the chamber and the bridge, wherein the insufflation flowpath passes through the first valve, and wherein the exsufflation flowpath does not pass through the first valve.
  • 18. The humidifier assembly of claim 17, further comprising a second valve disposed in the bridge at a position between the first conduit and the second conduit, wherein the exsufflation flowpath passes through the second valve, and wherein the insufflation flowpath does not pass through the second valve.
  • 19. A method for providing cough assistance to a patient, the method comprising: delivering insufflating gas from a cough-assist device to a patient via a patient circuit having a first conduit, a second conduit, and a humidifier between the first conduit and the second conduit, wherein delivering the insufflating gas comprises passing the insufflating gas through the first conduit, the second conduit, and a chamber in the humidifier, thereby humidifying the insufflating gas before it reaches the patient; andwithdrawing exsufflating gas from the patient via the first conduit and the second conduit of the patient circuit, wherein the humidifier remains connected to the first conduit and the second conduit as the gas is withdrawn, and wherein at least a portion of the exsufflating gas bypasses the humidifier.
  • 20. The method of claim 19 wherein withdrawing exsufflating gas comprises providing a pressure between negative 30-70 cm H2O in the patient circuit.
  • 21. The method of claim 19 wherein withdrawing the exsufflating gas comprises passing at least a portion of the exsufflating gas through a bypass coupled to the humidifier.
  • 22. The method of claim 21 wherein the bypass comprises: a first valve configured to (a) open while delivering the insufflating gas so that the insufflating gas from the cough-assist device passes through the chamber in the humidifier and (b) close in the presence of exsufflating gas to prevent exsufflating gas from exiting the chamber; anda second valve configured to (a) open while withdrawing the exsufflating gas from the patient circuit so that at least the portion of the exsufflating gas passes to the cough-assist device without passing through the chamber and (b) to close in the presence of insufflating gas.
CROSS-CITED TO RELATED APPLICATIONS

The present application is a Continuation of U.S. patent application Ser. No. 15/188,722, filed Jun. 21, 2016, now pending, which is incorporated herein by reference in its entirety.

US Referenced Citations (622)
Number Name Date Kind
3191596 Bird Jun 1965 A
3234932 Bird Feb 1966 A
3766914 Jacobs Oct 1973 A
3789837 Philips et al. Feb 1974 A
3806102 Valenta et al. Apr 1974 A
3875626 Tysk et al. Apr 1975 A
4280399 Cunning Jul 1981 A
4331455 Sato May 1982 A
4357936 Eliestad et al. Nov 1982 A
4367767 Hurd Jan 1983 A
4386945 Gardner Jun 1983 A
4401116 Fry et al. Aug 1983 A
4417573 De Vries Nov 1983 A
4425914 Ray et al. Jan 1984 A
4449990 Tedford, Jr. May 1984 A
4450838 Miodownik May 1984 A
4459982 Fry Jul 1984 A
4502481 Christian Mar 1985 A
4502873 Mottram et al. Mar 1985 A
4516424 Rowland May 1985 A
4527557 Devries et al. Jul 1985 A
4545790 Miller et al. Oct 1985 A
4561287 Rowland Dec 1985 A
4576616 Mottram et al. Mar 1986 A
4602653 Ruiz-vela et al. Jul 1986 A
4621632 Bartels et al. Nov 1986 A
4627860 Rowland Dec 1986 A
4637386 Baum Jan 1987 A
4648395 Sato et al. Mar 1987 A
4648888 Rowland Mar 1987 A
4681099 Sato et al. Jul 1987 A
4682591 Jones Jul 1987 A
4702240 Chaoui Oct 1987 A
4722334 Blackmer Feb 1988 A
4794922 Devries Jan 1989 A
4807616 Adahan Feb 1989 A
4813979 Miller et al. Mar 1989 A
4869733 Stanford Sep 1989 A
4880443 Miller et al. Nov 1989 A
4905685 Olsson et al. Mar 1990 A
4936297 Greiff et al. Jun 1990 A
4941469 Adahan Jul 1990 A
4971609 Pawlos Nov 1990 A
4983190 Verrando et al. Jan 1991 A
4993269 Guillaume et al. Feb 1991 A
5002591 Stanford Mar 1991 A
5014694 Devries May 1991 A
5021137 Joshi et al. Jun 1991 A
5024219 Dietz Jun 1991 A
5034023 Thompson Jul 1991 A
5071453 Hradek et al. Dec 1991 A
5072729 Devries Dec 1991 A
5101656 Miller Apr 1992 A
5107831 Halpern et al. Apr 1992 A
5127400 Devries et al. Jul 1992 A
5129924 Schultz Jul 1992 A
5134329 Lang Jul 1992 A
5161525 Kimm et al. Nov 1992 A
5166563 Bassine Nov 1992 A
5169506 Michaels Dec 1992 A
5186793 Michaels Feb 1993 A
5265594 Olsson et al. Nov 1993 A
5273031 Olsson et al. Dec 1993 A
5275642 Bassine Jan 1994 A
5296110 Tabatabaie-raissi Mar 1994 A
5331995 Westfall et al. Jul 1994 A
5335426 Settlemyer et al. Aug 1994 A
5354361 Coffield Oct 1994 A
5370112 Perkins Dec 1994 A
5378345 Taylor et al. Jan 1995 A
5397443 Michaels Mar 1995 A
5400777 Olsson et al. Mar 1995 A
5469372 Mcbrearty et al. Nov 1995 A
5474062 Devires et al. Dec 1995 A
5474595 Mccombs Dec 1995 A
5494028 Devries et al. Feb 1996 A
5497767 Olsson et al. Mar 1996 A
5501212 Psaros Mar 1996 A
5540220 Gropper et al. Jul 1996 A
5540233 Larsson et al. Jul 1996 A
5575283 Sjoestrand Nov 1996 A
5578115 Cole Nov 1996 A
5676133 Hickle et al. Oct 1997 A
5694924 Cewers Dec 1997 A
5694926 Devries et al. Dec 1997 A
5701883 Hete et al. Dec 1997 A
5706801 Remes et al. Jan 1998 A
5720277 Olsson et al. Feb 1998 A
5740796 Skog Apr 1998 A
5743253 Castor et al. Apr 1998 A
5746806 Aylsworth et al. May 1998 A
5765557 Warters Jun 1998 A
5765558 Psaros et al. Jun 1998 A
5766310 Cramer Jun 1998 A
5810324 Eriksson et al. Sep 1998 A
5827358 Kulish et al. Oct 1998 A
5845633 Psaros Dec 1998 A
5849219 De Laat et al. Dec 1998 A
5858062 Mcculloh et al. Jan 1999 A
5858063 Cao et al. Jan 1999 A
5862802 Bird Jan 1999 A
5868133 Devries et al. Feb 1999 A
5871564 Mccombs Feb 1999 A
5875777 Eriksson Mar 1999 A
5878744 Pfeiffer Mar 1999 A
5881722 Devries et al. Mar 1999 A
5890490 Aylsworth Apr 1999 A
5893944 Dong Apr 1999 A
5896857 Hely et al. Apr 1999 A
5906672 Michaels et al. May 1999 A
5917135 Michaels et al. Jun 1999 A
5931162 Christian Aug 1999 A
5937853 Stroem Aug 1999 A
5948142 Holmes et al. Sep 1999 A
5957130 Krahbichler et al. Sep 1999 A
5968236 Bassine Oct 1999 A
5988165 Richey, II et al. Nov 1999 A
5997617 Czabala et al. Dec 1999 A
6010555 Smolarek et al. Jan 2000 A
6035851 Wallen Mar 2000 A
6062218 Krahbichler et al. May 2000 A
6068680 Kulish et al. May 2000 A
6073630 Adahan Jun 2000 A
6095139 Psaros Aug 2000 A
6102038 Devries Aug 2000 A
6112744 Hognelid Sep 2000 A
6113673 Loutfy et al. Sep 2000 A
6123074 Hete et al. Sep 2000 A
6152132 Psaros Nov 2000 A
6152134 Webber et al. Nov 2000 A
6152135 Devries et al. Nov 2000 A
6155252 Warters Dec 2000 A
6156100 Conrad et al. Dec 2000 A
6158430 Pfeiffer et al. Dec 2000 A
6162283 Conrad et al. Dec 2000 A
6176897 Keefer Jan 2001 B1
6186142 Schmidt et al. Feb 2001 B1
6189532 Hely et al. Feb 2001 B1
6190441 Czabala et al. Feb 2001 B1
6192885 Jalde Feb 2001 B1
6217635 Conrad et al. Apr 2001 B1
6234170 Bergkvist May 2001 B1
6253767 Mantz Jul 2001 B1
6263873 Hedenberg Jul 2001 B1
6269811 Duff Aug 2001 B1
6298848 Skog Oct 2001 B1
6302107 Richey, II et al. Oct 2001 B1
6344069 Smolarek et al. Feb 2002 B2
6346139 Czabala Feb 2002 B1
6348082 Murdoch et al. Feb 2002 B1
6360740 Ward et al. Mar 2002 B1
6386235 Mcculloh et al. May 2002 B1
6393802 Bowser et al. May 2002 B1
6394089 Cantrill et al. May 2002 B1
6395065 Murdoch et al. May 2002 B1
6412483 Jones et al. Jul 2002 B1
6446630 Todd, Jr. Sep 2002 B1
6471744 Hill Oct 2002 B1
6478850 Warren Nov 2002 B2
6478857 Czabala Nov 2002 B2
6497755 Murdoch et al. Dec 2002 B2
6514318 Keefer Feb 2003 B2
6514319 Keefer et al. Feb 2003 B2
6516798 Davies Feb 2003 B1
6520176 Dubois et al. Feb 2003 B1
6524370 Maheshwary et al. Feb 2003 B2
6526970 Devries et al. Mar 2003 B2
6532956 Hill Mar 2003 B2
6547851 Warren Apr 2003 B2
6551384 Ackley et al. Apr 2003 B1
6553992 Berthon-jones et al. Apr 2003 B1
6558451 Mccombs et al. May 2003 B2
6564798 Jalde May 2003 B1
6565635 Keefer et al. May 2003 B2
6595213 Bennarsten Jul 2003 B2
6601583 Pessala et al. Aug 2003 B2
6622726 Du Sep 2003 B1
6626175 Jafari et al. Sep 2003 B2
6629525 Hill et al. Oct 2003 B2
6640807 Bennarsten Nov 2003 B2
6641644 Jagger et al. Nov 2003 B2
6641645 Lee et al. Nov 2003 B1
6644312 Berthon-Jones et al. Nov 2003 B2
6651652 Waard Nov 2003 B1
6651658 Hill et al. Nov 2003 B1
6651692 Meckes et al. Nov 2003 B2
6660065 Byrd et al. Dec 2003 B2
6668828 Figley et al. Dec 2003 B1
6679258 Stroem Jan 2004 B1
6691702 Appel et al. Feb 2004 B2
6694978 Bennarsten Feb 2004 B1
6702880 Roberts et al. Mar 2004 B2
6712876 Cao et al. Mar 2004 B2
6712877 Cao et al. Mar 2004 B2
6739334 Valeij May 2004 B2
6740146 Simonds May 2004 B2
6755193 Berthon-jones et al. Jun 2004 B2
6758216 Berthon-jones et al. Jul 2004 B1
6761166 Ahlmen et al. Jul 2004 B2
6764534 Mccombs et al. Jul 2004 B2
6782888 Friberg et al. Aug 2004 B1
6793719 Kim et al. Sep 2004 B2
6805122 Richey, II et al. Oct 2004 B2
6811590 Lee et al. Nov 2004 B2
6837244 Yagi et al. Jan 2005 B2
6845773 Berthon-jones et al. Jan 2005 B2
6860858 Green et al. Mar 2005 B2
6863068 Jamison et al. Mar 2005 B2
6866700 Amann Mar 2005 B2
6877511 Devries et al. Apr 2005 B2
6889726 Richey et al. May 2005 B2
6896721 Lynn May 2005 B1
6908503 Mccombs et al. Jun 2005 B2
6910480 Berthon-jones Jun 2005 B1
6923180 Richey, II et al. Aug 2005 B2
6935460 Mccombs et al. Aug 2005 B2
6949133 Mccombs et al. Sep 2005 B2
6997881 Green et al. Feb 2006 B2
7000610 Bennarsten et al. Feb 2006 B2
7032592 Castor et al. Apr 2006 B2
7040318 Daescher et al. May 2006 B2
7055522 Berthon-jones Jun 2006 B2
7066985 Deane et al. Jun 2006 B2
7077133 Yagi et al. Jul 2006 B2
7081745 Haveri Jul 2006 B2
7089937 Berthon-jones et al. Aug 2006 B2
7094275 Keefer et al. Aug 2006 B2
7096866 Be′eri et al. Aug 2006 B2
7100609 Berthon-Jones et al. Sep 2006 B2
7105038 Lee et al. Sep 2006 B2
7121276 Jagger et al. Oct 2006 B2
7121277 Stroem Oct 2006 B2
7135059 Deane et al. Nov 2006 B2
7156903 Mccombs Jan 2007 B2
7171963 Jagger et al. Feb 2007 B2
7179326 Nakamura et al. Feb 2007 B2
7188621 DeVries et al. Mar 2007 B2
7213468 Fujimoto May 2007 B2
7219666 Friberg et al. May 2007 B2
7222623 Devries et al. May 2007 B2
7250073 Keefer et al. Jul 2007 B2
7255103 Bassin Aug 2007 B2
7279029 Occhialini et al. Oct 2007 B2
7294170 Richey, II et al. Nov 2007 B2
7329304 Bliss et al. Feb 2008 B2
7347207 Ahlmen et al. Mar 2008 B2
7350521 Whitley et al. Apr 2008 B2
7367337 Berthon-jones et al. May 2008 B2
7368005 Bliss et al. May 2008 B2
RE40402 Leonhardt et al. Jun 2008 E
7402193 Bliss et al. Jul 2008 B2
7406966 Wondka Aug 2008 B2
7427315 Dolensky et al. Sep 2008 B2
7428902 Du et al. Sep 2008 B2
7429289 Dolensky et al. Sep 2008 B2
7431032 Jagger et al. Oct 2008 B2
7438745 Deane et al. Oct 2008 B2
7445546 Hondmann et al. Nov 2008 B2
7445663 Hunter et al. Nov 2008 B1
7455717 Sprinkle Nov 2008 B2
7473299 Occhialini et al. Jan 2009 B2
7491261 Warren et al. Feb 2009 B2
7497215 Nguyen et al. Mar 2009 B1
7510601 Whitley et al. Mar 2009 B2
7517385 Winter Apr 2009 B2
7524365 Lin Apr 2009 B2
7527053 Devries et al. May 2009 B2
7533872 Lee et al. May 2009 B2
7550031 Hunter et al. Jun 2009 B2
7550036 Lee et al. Jun 2009 B2
7556670 Aylsworth et al. Jul 2009 B2
7559326 Smith et al. Jul 2009 B2
7585351 Deane et al. Sep 2009 B2
7590551 Auer Sep 2009 B2
7604004 Jagger et al. Oct 2009 B2
7604005 Jagger et al. Oct 2009 B2
7628151 Bassin Dec 2009 B2
7637989 Bong Dec 2009 B2
7655059 Wang et al. Feb 2010 B2
7655063 Wang et al. Feb 2010 B2
7682428 Nawata et al. Mar 2010 B2
7682429 Dolensky et al. Mar 2010 B2
7686870 Deane et al. Mar 2010 B1
7704304 Warren et al. Apr 2010 B2
7708802 Deane et al. May 2010 B1
7708818 Clark May 2010 B2
7717981 Labuda et al. May 2010 B2
7722700 Sprinkle May 2010 B2
7727160 Green et al. Jun 2010 B2
7730887 Deane et al. Jun 2010 B2
7753996 Deane et al. Jul 2010 B1
7758672 Lee et al. Jul 2010 B2
7763103 Dolensky et al. Jul 2010 B2
7766010 Jagger et al. Aug 2010 B2
7771511 Dolensky Aug 2010 B2
7780768 Taylor et al. Aug 2010 B2
7780769 Dolensky et al. Aug 2010 B2
7794522 Bliss et al. Sep 2010 B2
7828878 Zhong et al. Nov 2010 B2
7837761 Bliss et al. Nov 2010 B2
7841343 Deane et al. Nov 2010 B2
7849854 Devries et al. Dec 2010 B2
7857894 Taylor et al. Dec 2010 B2
7861716 Borrello Jan 2011 B2
7866315 Jagger et al. Jan 2011 B2
7874290 Chalvignac Jan 2011 B2
7875105 Chambers et al. Jan 2011 B2
7892322 Ono et al. Feb 2011 B2
7909034 Sinderby et al. Mar 2011 B2
7914459 Green et al. Mar 2011 B2
7918925 Dolensky et al. Apr 2011 B2
7922789 Deane et al. Apr 2011 B1
7934498 Heidelberger May 2011 B1
7934499 Berthon-jones May 2011 B2
7954493 Nawata Jun 2011 B2
8006692 Smith et al. Aug 2011 B2
8016916 Ono et al. Sep 2011 B2
8016918 Labuda et al. Sep 2011 B2
8016925 Mccombs et al. Sep 2011 B2
8020553 Jagger et al. Sep 2011 B2
8051852 Bassin Nov 2011 B2
8062003 Goertzen Nov 2011 B2
8070853 Sprinkle Dec 2011 B2
8070864 Uchiyama et al. Dec 2011 B2
8070922 Nelson et al. Dec 2011 B2
8075676 Thompson et al. Dec 2011 B2
8100125 Duquette et al. Jan 2012 B2
8118024 Devries et al. Feb 2012 B2
8122885 Berthon-jones et al. Feb 2012 B2
8123497 Richey, II et al. Feb 2012 B2
8142544 Taylor et al. Mar 2012 B2
8146596 Smith et al. Apr 2012 B2
8147597 Dolensky et al. Apr 2012 B2
8156937 Devries et al. Apr 2012 B2
8167988 Dolensky et al. May 2012 B2
8192526 Zhong et al. Jun 2012 B2
8210205 Michaels Jul 2012 B2
8225789 Berthon-jones Jul 2012 B2
8226745 Siew-wah et al. Jul 2012 B2
8236095 Bassine Aug 2012 B1
8256419 Sinderby et al. Sep 2012 B2
8257473 Mccombs et al. Sep 2012 B2
8280498 Jalde Oct 2012 B2
8282717 Chambers et al. Oct 2012 B2
8297279 Devries et al. Oct 2012 B2
8337599 Kiritake Dec 2012 B2
8343259 Knaebel Jan 2013 B2
8349053 Lee et al. Jan 2013 B2
8361204 Bassine Jan 2013 B1
8366815 Taylor et al. Feb 2013 B2
8371298 Hallback et al. Feb 2013 B2
8375944 Kwok Feb 2013 B2
8377180 Maeda et al. Feb 2013 B2
8377181 Taylor et al. Feb 2013 B2
8388548 Green et al. Mar 2013 B2
8388745 Pelletier et al. Mar 2013 B1
8400290 Baker, Jr. Mar 2013 B2
8418691 Jafari et al. Apr 2013 B2
8418692 Sanchez Apr 2013 B2
8424520 Thiessen Apr 2013 B2
8424521 Jafari et al. Apr 2013 B2
8428672 Sherman et al. Apr 2013 B2
8434480 Jafari et al. May 2013 B2
8434482 Borrello May 2013 B2
8434488 Li et al. May 2013 B2
8435013 Kondou et al. May 2013 B2
8440004 Taylor et al. May 2013 B2
8443294 Skidmore et al. May 2013 B2
8448640 Bassin May 2013 B2
8448641 Jafari et al. May 2013 B2
8469026 Blomberg et al. Jun 2013 B2
8522780 Devries et al. Sep 2013 B2
8539952 Carbone et al. Sep 2013 B2
8627819 Devries et al. Jan 2014 B2
8683997 Devries et al. Apr 2014 B2
8770191 Tham Jul 2014 B2
8844530 Birnkrant Sep 2014 B2
9126002 Devries et al. Sep 2015 B2
9345851 Kim et al. May 2016 B2
9504799 Hardin et al. Nov 2016 B2
9956371 DeVries May 2018 B2
10046134 DeVries Aug 2018 B2
10105509 DeVries Oct 2018 B2
10245406 Devries Apr 2019 B2
10315002 Devries et al. Jun 2019 B2
10350377 Fiorenza Jul 2019 B2
10518059 Cipollone et al. Dec 2019 B2
10758699 Cipollone et al. Sep 2020 B2
10773049 Gaw et al. Sep 2020 B2
11191915 Ahmad Dec 2021 B2
20020005197 DeVries Jan 2002 A1
20020053286 Czabala May 2002 A1
20020092420 Jagger et al. Jul 2002 A1
20020121278 Hete Sep 2002 A1
20030000531 Tuck Jan 2003 A1
20030010208 Jagger et al. Jan 2003 A1
20030024766 Briscoe Feb 2003 A1
20030051729 Be'eri et al. Mar 2003 A1
20030111077 Hooser Jun 2003 A1
20030131848 Stenzler Jul 2003 A1
20030196550 Keefer et al. Oct 2003 A1
20030200865 Mccombs et al. Oct 2003 A1
20030230308 Linden Dec 2003 A1
20040021108 Hallback et al. Feb 2004 A1
20040231913 Mccombs et al. Nov 2004 A1
20050012657 Mohan Jan 2005 A1
20050045040 Mccombs Mar 2005 A1
20050072298 Deane et al. Apr 2005 A1
20050072306 Deane et al. Apr 2005 A1
20050072423 Deane et al. Apr 2005 A1
20050072426 Deane et al. Apr 2005 A1
20050103341 Deane et al. May 2005 A1
20050112013 Devries et al. May 2005 A1
20050217481 Dunne et al. Oct 2005 A1
20050257686 Occhialini et al. Nov 2005 A1
20050274381 Deane et al. Dec 2005 A1
20050274815 Bergholtz et al. Dec 2005 A1
20060011065 Hastings Jan 2006 A1
20060042631 Martin et al. Mar 2006 A1
20060064802 Damrath et al. Mar 2006 A1
20060086251 Sprinkle Apr 2006 A1
20060102181 Mccombs et al. May 2006 A1
20060107947 Rist May 2006 A1
20060117957 Mccombs et al. Jun 2006 A1
20060137522 Nishimura et al. Jun 2006 A1
20060174871 Jagger et al. Aug 2006 A1
20060174875 Jagger et al. Aug 2006 A1
20060174877 Jagger et al. Aug 2006 A1
20060230924 Deane et al. Oct 2006 A1
20060230929 Bliss et al. Oct 2006 A1
20060230931 Bliss et al. Oct 2006 A1
20060230939 Bliss et al. Oct 2006 A1
20060266357 Mccombs et al. Nov 2006 A1
20060283325 Sugano Dec 2006 A1
20060283447 Dhuper et al. Dec 2006 A1
20070031302 Wittrup et al. Feb 2007 A1
20070056583 Jagger et al. Mar 2007 A1
20070056584 Jagger et al. Mar 2007 A1
20070084342 Hunter et al. Apr 2007 A1
20070084349 Calkins et al. Apr 2007 A1
20070101999 Duquette et al. May 2007 A1
20070135757 Acker Jun 2007 A1
20070144521 Devries et al. Jun 2007 A1
20070148016 Crawford et al. Jun 2007 A1
20070169623 Lee et al. Jul 2007 A1
20070199566 Be'eri Aug 2007 A1
20070214955 Aylsworth et al. Sep 2007 A1
20070227360 Atlas et al. Oct 2007 A1
20070227540 Ljungberg et al. Oct 2007 A1
20070272243 Sherman et al. Nov 2007 A1
20070289446 Occhialini et al. Dec 2007 A1
20080000477 Huster et al. Jan 2008 A1
20080004566 Sloan Jan 2008 A1
20080028933 Ross et al. Feb 2008 A1
20080034975 Chambers et al. Feb 2008 A1
20080053441 Gottlib Mar 2008 A1
20080066616 Sprinkle Mar 2008 A1
20080066741 LeMahieu et al. Mar 2008 A1
20080087170 Deane et al. Apr 2008 A1
20080092892 Boyle et al. Apr 2008 A1
20080092893 Boyle et al. Apr 2008 A1
20080110338 Taylor et al. May 2008 A1
20080110461 Mulqueeny et al. May 2008 A1
20080135044 Freitag et al. Jun 2008 A1
20080185544 Yeh Aug 2008 A1
20080196580 Bliss et al. Aug 2008 A1
20080202337 Taylor et al. Aug 2008 A1
20080202508 Mcclain et al. Aug 2008 A1
20080251071 Armitstead et al. Oct 2008 A1
20080257145 Sprinkle et al. Oct 2008 A1
20080257349 Hedner et al. Oct 2008 A1
20080282880 Bliss et al. Nov 2008 A1
20080295839 Habashi Dec 2008 A1
20080302362 Kwok Dec 2008 A1
20080302363 Kroupa Dec 2008 A1
20080314385 Brunner et al. Dec 2008 A1
20080315441 Lee et al. Dec 2008 A1
20090007912 Lindell et al. Jan 2009 A1
20090025560 Takemasa Jan 2009 A1
20090025564 Kuwabara Jan 2009 A1
20090044698 Meacham Feb 2009 A1
20090065526 Sprinkle Mar 2009 A1
20090065907 Wilkinson et al. Mar 2009 A1
20090071333 Labuda et al. Mar 2009 A1
20090078251 Zucchi et al. Mar 2009 A1
20090084381 Devries et al. Apr 2009 A1
20090101147 Landis et al. Apr 2009 A1
20090107500 Edwards Apr 2009 A1
20090133368 Calkins et al. May 2009 A1
20090133694 Solci et al. May 2009 A1
20090145428 Sward et al. Jun 2009 A1
20090167698 Altas et al. Jul 2009 A1
20090188502 Tiedje Jul 2009 A1
20090211448 Mcclain Aug 2009 A1
20090229459 Warren et al. Sep 2009 A1
20090250059 Allum et al. Oct 2009 A1
20090301477 Pierro et al. Dec 2009 A1
20090308396 Mcclain Dec 2009 A1
20100024819 Tiedje Feb 2010 A1
20100051030 Richard et al. Mar 2010 A1
20100052293 Brooks et al. Mar 2010 A1
20100071693 Allum et al. Mar 2010 A1
20100078018 Heinonen Apr 2010 A1
20100095841 Naheiri Apr 2010 A1
20100116270 Branson et al. May 2010 A1
20100122699 Bimkrant May 2010 A1
20100126249 Matsuzaki May 2010 A1
20100154797 Landis et al. Jun 2010 A1
20100229867 Bertinetti et al. Sep 2010 A1
20100275921 Schindhelm et al. Nov 2010 A1
20100282084 Hansen et al. Nov 2010 A1
20100288279 Seiver et al. Nov 2010 A1
20100294127 Dolensky Nov 2010 A1
20110000489 Laksov et al. Jan 2011 A1
20110030684 Wilkinson et al. Feb 2011 A1
20110030685 Wilkinson et al. Feb 2011 A1
20110030686 Wilkinson et al. Feb 2011 A1
20110030687 Wilkinson et al. Feb 2011 A1
20110030689 Wilkinson et al. Feb 2011 A1
20110057651 Duric et al. Mar 2011 A1
20110067699 Caruso et al. Mar 2011 A1
20110073107 Rodman et al. Mar 2011 A1
20110073115 Wood et al. Mar 2011 A1
20110113964 Chambers et al. May 2011 A1
20110154986 Lee et al. Jun 2011 A1
20110192122 Whitesel et al. Aug 2011 A1
20110197882 Truschel et al. Aug 2011 A1
20110197883 Mcdaniel et al. Aug 2011 A1
20110197884 Duff et al. Aug 2011 A1
20110197887 Truschel et al. Aug 2011 A1
20110209706 Truschel et al. Sep 2011 A1
20110209707 Terhark Sep 2011 A1
20110220107 Kimm et al. Sep 2011 A1
20110232483 Haberiand et al. Sep 2011 A1
20110232645 Smith Sep 2011 A1
20110247616 Von Hollen et al. Oct 2011 A1
20110247620 Armstrong et al. Oct 2011 A1
20110247621 Richard et al. Oct 2011 A1
20110247622 Schneider et al. Oct 2011 A1
20110259334 Alfieri et al. Oct 2011 A1
20110297153 Grimsey Dec 2011 A1
20110303223 Kane et al. Dec 2011 A1
20110315140 Shuman Dec 2011 A1
20120000462 Edwards et al. Jan 2012 A1
20120006199 Mccombs et al. Jan 2012 A1
20120006326 Ahmad Jan 2012 A1
20120012109 Chalvignac Jan 2012 A1
20120017909 Porges et al. Jan 2012 A1
20120027628 Ogawa Feb 2012 A1
20120037159 Mulqueeny et al. Feb 2012 A1
20120055340 Wilkinson et al. Mar 2012 A1
20120055474 Wilkinson Mar 2012 A1
20120055475 Wilkinson Mar 2012 A1
20120055477 Wilkinson Mar 2012 A1
20120055480 Wilkinson Mar 2012 A1
20120055482 Wilkinson Mar 2012 A1
20120055483 Wilkinson et al. Mar 2012 A1
20120060840 Refsland et al. Mar 2012 A1
20120125336 Berthon-jones et al. May 2012 A1
20120125337 Asanoi May 2012 A1
20120152248 Richey, II et al. Jun 2012 A1
20120167883 Taylor et al. Jul 2012 A1
20120167886 Taylor et al. Jul 2012 A1
20120167887 Taylor et al. Jul 2012 A1
20120167888 Taylor et al. Jul 2012 A1
20120177546 Hilbig Jul 2012 A1
20120192862 Lewis et al. Aug 2012 A1
20120192864 Galbraith et al. Aug 2012 A1
20120192867 Lewis et al. Aug 2012 A1
20120247329 Hilbig Oct 2012 A1
20120266883 Taylor et al. Oct 2012 A1
20120285460 Smith et al. Nov 2012 A1
20120285543 Michaels Nov 2012 A1
20120291884 Yamaura et al. Nov 2012 A1
20120304867 Watanabe et al. Dec 2012 A1
20120308779 Klee et al. Dec 2012 A1
20120318145 Hilbig et al. Dec 2012 A1
20130008438 Sugawara et al. Jan 2013 A1
20130008444 Chalvignac et al. Jan 2013 A1
20130025591 Clark et al. Jan 2013 A1
20130031784 Chambers et al. Feb 2013 A1
20130032148 Neely Feb 2013 A1
20130081617 Cavendish Apr 2013 A1
20130087145 Koebrich et al. Apr 2013 A1
20130087146 Callaghan et al. Apr 2013 A1
20130092159 Ulrichskoetter et al. Apr 2013 A1
20130098361 Koebrich et al. Apr 2013 A1
20130104898 Berthon-jones May 2013 A1
20130125891 Eddy May 2013 A1
20130167843 Kimm et al. Jul 2013 A1
20130186400 Jafari et al. Jul 2013 A1
20130186401 Jafari et al. Jul 2013 A1
20130199520 Dhuper et al. Aug 2013 A1
20130220325 Davis et al. Aug 2013 A1
20130255689 Kim et al. Oct 2013 A1
20130272905 Shelke Oct 2013 A1
20130276789 Garde et al. Oct 2013 A1
20130312757 Gragg et al. Nov 2013 A1
20140007878 Armistead et al. Jan 2014 A1
20140116441 Mcdaniel May 2014 A1
20140150789 Flanagan et al. Jun 2014 A1
20140150791 Birnkrant et al. Jun 2014 A1
20140150792 Christopher et al. Jun 2014 A1
20140166009 Flanagan et al. Jun 2014 A1
20140216446 Wruck Aug 2014 A1
20140318535 Bullock Oct 2014 A1
20140373835 Ahmad et al. Dec 2014 A1
20150000654 Martin Jan 2015 A1
20150000660 Martin Jan 2015 A1
20150027444 Col, Jr. Jan 2015 A1
20150101610 Nitta Apr 2015 A1
20150224278 Addington et al. Aug 2015 A1
20150283352 Karkkainen Oct 2015 A1
20150320962 Bafile Nov 2015 A1
20160095997 Kapust et al. Apr 2016 A1
20160243330 Destefano Aug 2016 A1
20160279369 Cipollone Sep 2016 A1
20160279378 Cipollone et al. Sep 2016 A1
20170000968 Harrington et al. Jan 2017 A1
20180085541 Ye et al. Mar 2018 A1
20190054268 DeVries Feb 2019 A1
20210252243 Barlow et al. Aug 2021 A1
Foreign Referenced Citations (40)
Number Date Country
102580201 Jul 2012 CN
103071215 May 2013 CN
0937478 Aug 2003 EP
2164568 Mar 1986 GB
2485417 May 2012 GB
H11-192410 Jul 1999 JP
H11-210927 Aug 1999 JP
2000024110 Jan 2000 JP
2000300673 Oct 2000 JP
2001507982 Jun 2001 JP
2002136598 May 2002 JP
2003156174 May 2003 JP
2007117273 May 2007 JP
2008501445 Jan 2008 JP
2008539841 Nov 2008 JP
2010535078 Nov 2010 JP
2012508074 Apr 2012 JP
201418030 Sep 2014 JP
1998022172 May 1998 WO
9826830 Jun 1998 WO
1999008738 Feb 1999 WO
0038772 Jul 2000 WO
2003008017 Jan 2003 WO
2003045486 Jun 2003 WO
2006102345 Sep 2006 WO
2006121980 Nov 2006 WO
2010054323 May 2010 WO
2010141983 Dec 2010 WO
2011161060 Dec 2011 WO
2012052903 Apr 2012 WO
2013033589 Mar 2013 WO
2013067592 May 2013 WO
2013140321 Sep 2013 WO
2013164733 Nov 2013 WO
2014059405 Apr 2014 WO
2014176454 Oct 2014 WO
2015015394 Feb 2015 WO
2015126853 Aug 2015 WO
2016067147 May 2016 WO
2017149532 Sep 2017 WO
Non-Patent Literature Citations (11)
Entry
US 8,012,240 B2, 09/2011, Sprinkle (withdrawn)
Branson, D R. et al., Branson, D. Richard et al., “Maximizing Oxygen Delivery During Mechanical Ventilation with a Portable Oxygen Concentrator,” The Journal of Trauma® Injury, Infection, and Critical Care, vol. 69, No. 1, July Supplement 2010, 7 pages., Jul. 2010, 7 pages.
Gandidine et al., “System Design Verification for Closed Loop Control of Oxygenation With Concentrator Integration,” Military Medicine, 2016, vol. 181 (5):177-183.
Gustafson, et al., Gustafson et al., “Pulse Dose Delivery of Oxygen in Mechanically Ventilated Pigs with Acute Lung Injury,” The Journal of Trauma and Acute Care Surgery, 75(5), Nov. 2013, pp. 775-779., 5 pages.
International Search Report and Written Opinion dated Sep. 6, 2017 in International Patent Application No. PCT/US2017/037738, 8 pages.
Rodriguez et al., “Maximizing Oxygen Delivery During Mechanical Ventilation with a Portable Oxygen Concentrator,” Journal of Trauma-Injury Infection & Critical Care, 69(1), Jul. 2020, pp. S87-S93.
Extended European Search Report dated Dec. 16, 2019 in European Patent Application No. 17815960.4, 6 pages.
Japanese Office Action dated Dec. 24, 2019 in Japanese Patent Application No. 2017-550238, 10 pages.
Chinese Office Action with English translation dated Apr. 13, 2020 in Chinese Patent Application No. 201680030445.1, 27 pages.
Japanese Office Action translation dated Apr. 14, 2021 in Japanese Patent Application No. 2018-566483, 9 pages.
Japense Office Action translation dated Nov. 7, 2022 in Japanese Patent Application No. 2021-215380, 5 pages.
Related Publications (1)
Number Date Country
20210196920 A1 Jul 2021 US
Continuations (1)
Number Date Country
Parent 15188722 Jun 2016 US
Child 16993113 US